Interferons and their stimulated genes in the tumor microenvironment
about
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesIdentification of a small molecule that primes the type I interferon response to cytosolic DNA.Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads.Combinations of immunotherapy and radiation in cancer therapy.Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.IFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathwayTranscriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenograftsCentral role of ULK1 in type I interferon signalingRoles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis.Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs.Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.Emerging roles of p53 and other tumour-suppressor genes in immune regulationIntracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?Interferons and the Immunogenic Effects of Cancer Therapy.Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer.IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer.Fine Tuning of a Type 1 Interferon Antagonist.p53 and the Carcinogenicity of Chronic Inflammation.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Role of Type I and II Interferons in Colorectal Cancer and Melanoma.STAT1-mediated translational control in tumor suppression and antitumor therapies.Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation.∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling.PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins.Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.Gene expression profile of human lung in a relatively early stage of COPD with emphysemaPlasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to ResistanceQ58736062
P2860
Q26767212-CE3FC67B-EB02-4881-BCD2-CC81017895F8Q33747178-9D884035-4FA0-4990-8DD6-6E94BC949038Q34493715-0122B6D9-481B-40AC-AFAD-7ABFC1528D2EQ34582640-A524D00B-B3AD-4EC1-A498-2D9D02B09A5DQ34656877-2CE58057-EC52-48EB-84B0-984925C046DBQ35230043-164D383B-CDE1-4FD1-A7D9-1AD1D4542067Q35624661-248E851E-AEB9-46A0-A80B-F0939D7CEF03Q35770740-4D972F6A-1ECA-49A6-927E-422D8EDE1646Q35989977-6506ACB8-1F30-42BF-91FA-6413F6312FB3Q36599823-ADF2E22E-568B-43F9-BCEB-25A634AB176DQ36629549-84365831-5D34-440A-84EA-8A5197E440E5Q37295712-18AC7E78-AE56-4C8E-AE09-A79B69DF9EC0Q37641644-8928A4F8-74FD-4ED8-9168-837C80B63A49Q37666015-A22B6683-08A3-4E04-AC66-7DC40C4EF3F9Q37718357-2B81B17A-448A-4A20-BFD8-0C303DE57F9FQ38293111-CD72151C-8640-4940-9F29-94C59B2F2777Q38398206-D138C0C4-0E5C-464B-B303-0370713534B3Q38697912-7807415E-1DE6-4DC7-99ED-D433FA766D28Q38707618-B8E62155-61D1-4756-9A4C-009B84914C78Q38765585-C237F34B-F59C-42FC-8979-4B6E4F4AB82AQ38839108-49347D44-B978-4584-A32C-FDB0E184FF0CQ38855055-8E4650E2-8A7F-4A02-B067-3CB361B62244Q38934157-9907B134-C446-4DF8-80EF-A845497F9A7FQ40444191-752CA675-9C56-491C-AC63-F1AE9ACD4956Q41123286-C335205F-4C3C-4D9F-9BF1-788F4A37C372Q42017931-4EF22508-357B-4B93-B393-851238680527Q48097366-66E4B940-EB61-43F3-AF18-56F75EBC7564Q48182143-E6BFBB2B-E0AC-49CD-BDF5-86020D86B0B8Q48223419-2891CEFE-01BF-40DD-A624-09F39C005C1FQ49865189-40BFA78C-002C-432E-905C-F1633365C10AQ49990366-8D847C95-308B-430B-AB4C-18B962D870E8Q51457076-AEF0924B-E2F8-4A48-AF02-1BA11FF8B81AQ55396890-67CBFDDE-F5C3-40C7-8FC3-AA27783009FAQ58698660-C0FDA98B-BD05-4E35-903C-EA55D8520E5BQ58729482-30C140FB-34D7-44D6-AEDE-B4758780EEE3Q58736062-FEB627C8-3AC9-4501-87D5-D36C1A1F7BA4
P2860
Interferons and their stimulated genes in the tumor microenvironment
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interferons and their stimulated genes in the tumor microenvironment
@ast
Interferons and their stimulated genes in the tumor microenvironment
@en
type
label
Interferons and their stimulated genes in the tumor microenvironment
@ast
Interferons and their stimulated genes in the tumor microenvironment
@en
prefLabel
Interferons and their stimulated genes in the tumor microenvironment
@ast
Interferons and their stimulated genes in the tumor microenvironment
@en
P2093
P2860
P1433
P1476
Interferons and their stimulated genes in the tumor microenvironment
@en
P2093
Ernest C Borden
George R Stark
Hyeonjoo Cheon
P2860
P304
P356
10.1053/J.SEMINONCOL.2014.02.002
P577
2014-02-14T00:00:00Z